Hiroko Otake
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Ophthalmology top 5%
- Retinal Diseases and Treatments
Papers in
-
- Advanced Drug Delivery Systems 18
- Advancements in Transdermal Drug Delivery 13
- Drug Solubulity and Delivery Systems 6
-
- Connexins and lens biology 7
- Co-authors
- Noriaki Nagai (59 shared papers)Fumihiko Ogata (24 shared papers)Naohito Kawasaki (23 shared papers)Yosuke Nakazawa (22 shared papers)Naoki Yamamoto (19 shared papers)Noriko Hiramatsu (7 shared papers)Norio Okamoto (8 shared papers)Hiroshi Sasaki (14 shared papers)
- Journals
- Pharmaceutics (13 papers)International Journal of Molecular Sciences (12 papers)International Journal of Nanomedicine (5 papers)Chemical and Pharmaceutical Bulletin (3 papers)Nanomaterials (2 papers)
- Partner nations
- JapanIndiaSaudi Arabia
In The Last Decade
Hiroko Otake
55 papers receiving 787 citations
Peers
Comparison fields: 5 of 88
- Pharmaceutical Science 322
- Ophthalmology 107
- Urology 42
- Public Health, Environmental and Occupational Health 178
- Biomaterials 81
Countries citing papers authored by Hiroko Otake
This map shows the geographic impact of Hiroko Otake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Otake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Otake more than expected).
Fields of papers citing papers by Hiroko Otake
This network shows the impact of papers produced by Hiroko Otake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Otake. The network helps show where Hiroko Otake may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Otake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 80 | |
| 2 | 2019 | 69 | |
| 3 | 2018 | 46 | |
| 4 | 2019 | 46 | |
| 5 | 2019 | 34 | |
| 6 | 2018 | 33 | |
| 7 | 2015 | 33 | |
| 8 | 2020 | 31 | |
| 9 | 2020 | 27 | |
| 10 | 2018 | 26 | |
| 11 | 2019 | 23 | |
| 12 | 2018 | 22 | |
| 13 | 2015 | 22 | |
| 14 | 2017 | 21 | |
| 15 | 2020 | 21 | |
| 16 | 2017 | 20 | |
| 17 | 2020 | 18 | |
| 18 | 2019 | 17 | |
| 19 | 2020 | 17 | |
| 20 | 2020 | 14 |
About Hiroko Otake
Hiroko Otake is a scholar working on Pharmaceutical Science, Molecular Biology, Ophthalmology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 62 papers that have together received 798 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (18 papers), Advancements in Transdermal Drug Delivery (13 papers), Ocular Surface and Contact Lens (13 papers), Retinal Diseases and Treatments (7 papers), Connexins and lens biology (7 papers), Corneal Surgery and Treatments (6 papers), Drug Solubulity and Delivery Systems (6 papers) and Glaucoma and retinal disorders (6 papers). The work is most often cited by research in Pharmaceutical Science (322 citations), Ophthalmology (107 citations), Urology (42 citations), Public Health, Environmental and Occupational Health (178 citations) and Biomaterials (81 citations). Hiroko Otake has collaborated with scholars based in Japan, India and Saudi Arabia. Frequent co-authors include Noriaki Nagai, Fumihiko Ogata, Naohito Kawasaki, Yosuke Nakazawa, Naoki Yamamoto, Noriko Hiramatsu, Norio Okamoto, Hiroshi Sasaki, Tomoyuki Okuda and K. Kánai. Their work appears in journals such as Pharmaceutics, International Journal of Molecular Sciences, International Journal of Nanomedicine, Chemical and Pharmaceutical Bulletin and Nanomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.